| Symbol | ENVB |
|---|---|
| Name | ENVERIC BIOSCIENCES, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 245 FIRST STREET,RIVERVIEW II,18TH FLOOR, CAMBRIDGE, Massachusetts, 02142, United States |
| Telephone | +1 617 - 444-8400 |
| Fax | — |
| — | |
| Website | https://www.enveric.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000890821 |
| Description | Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Additional info from NASDAQ: |
Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
Read moreEnveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
Read moreEnveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical Model
Read moreNew Form D - Enveric Biosciences, Inc. <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0000890821-26-000002 <b>Size:</b> 13 KB
Read moreNew Form DEFA14A - Enveric Biosciences, Inc. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0001493152-26-020405 <b>Size:</b> 1 MB
Read moreNew Form EFFECT - Enveric Biosciences, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 9999999995-26-001390 <b>Size:</b> 1 KB
Read moreNew Form 424B3 - Enveric Biosciences, Inc. <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0001493152-26-019676 <b>Size:</b> 190 KB
Read moreEnveric Biosciences to Participate Panel Discussion at Needham’s Virtual Psychedelics Forum
Read moreEnveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Read moreNew Form ARS - Enveric Biosciences, Inc. <b>Filed:</b> 2026-04-14 <b>AccNo:</b> 0001493152-26-016546 <b>Size:</b> 1 MB
Read more